当前位置:首页 - 行情中心 - 东方生物(688298) - 财务分析 - 资产负债表

东方生物

(688298)

  

流通市值:73.48亿  总市值:73.48亿
流通股本:2.02亿   总股本:2.02亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金2,862,715,435.643,042,661,596.653,461,879,336.554,164,735,978.75
应收票据及应收账款272,856,154.48273,098,270.39223,266,588.45207,736,254.65
其中:应收票据1,804,684.991,343,8701,917,744.251,573,180
应收账款271,051,469.49271,754,400.39221,348,844.2206,163,074.65
预付款项37,836,957.1240,893,926.7540,486,982.8128,607,903.43
其他应收款合计20,365,778.3123,551,802.2530,027,866.8420,701,287.53
存货427,260,228.2426,262,260.06384,971,322.46346,775,187.97
其他流动资产95,749,351.2390,573,049.8392,898,828.9775,401,614.1
流动资产平衡项目0000
流动资产合计4,560,590,159.964,805,209,149.175,271,199,464.935,896,256,738.14
非流动资产:
长期股权投资19,552,807.8819,693,600.2620,374,348.0621,235,457.08
其他非流动金融资产30,727,585.0530,869,031.6130,998,302.6831,114,730.78
投资性房地产19,725,521.6519,884,514.09--
固定资产1,480,517,831.211,496,124,317.331,413,313,631.81,408,476,667.38
在建工程964,133,871.35886,471,113.89830,138,237.32796,483,365.12
使用权资产71,998,913.3273,517,267.9479,598,579.3556,211,004.41
无形资产712,952,668.84733,297,562.46481,750,208.54478,814,433.79
商誉55,367,499.5755,367,499.5745,625,034.22-
长期待摊费用61,443,673.565,150,659.4958,243,446.7561,050,149.04
递延所得税资产233,749,890.27227,339,767.97227,361,997.93218,256,291.09
其他非流动资产23,643,591.2830,018,347.63300,750,937.8528,052,313.91
非流动资产平衡项目0000
非流动资产合计3,673,813,853.923,637,733,682.243,488,154,724.53,099,694,412.6
资产平衡项目0000
资产总计8,234,404,013.888,442,942,831.418,759,354,189.438,995,951,150.74
流动负债:
短期借款186,735,657.38186,711,935.39176,773,891.67198,221,896.67
交易性金融负债---15,830,213.93
应付票据及应付账款380,038,865.78392,870,582.65363,836,178.25600,485,929.48
其中:应付票据3,000,0004,200,00013,538,724.1325,760,319.32
应付账款377,038,865.78388,670,582.65350,297,454.12574,725,610.16
合同负债33,556,760.7834,702,545.1533,966,055.3434,768,741.84
应付职工薪酬40,731,287.0137,230,341.7834,311,006.3761,156,537.24
应交税费3,696,722.742,558,758.313,464,472.2411,579,674.96
其他应付款合计143,521,360.39157,700,097.9156,636,231.7696,341,168.22
一年内到期的非流动负债324,199,973.87373,126,703.15374,439,141.3366,156,620.82
其他流动负债1,488,852.841,681,242.231,897,321.261,246,500.81
流动负债平衡项目0000
流动负债合计1,113,969,480.791,186,582,206.561,145,324,298.221,085,787,283.97
非流动负债:
长期借款---300,000,000
租赁负债53,160,520.6653,502,584.6761,003,718.543,955,287.29
预计负债5,906,9435,697,0905,670,2525,695,893
递延收益10,110,237.5410,322,996.2210,535,754.8910,748,513.56
递延所得税负债29,510.2966,060.68-36,024.89
非流动负债平衡项目0000
非流动负债合计69,207,211.4969,588,731.5777,209,725.39360,435,718.74
负债平衡项目0000
负债合计1,183,176,692.281,256,170,938.131,222,534,023.611,446,223,002.71
所有者权益(或股东权益):
实收资本(或股本)201,600,000201,600,000201,600,000201,600,000
资本公积396,393,270.49395,773,417.88395,773,417.88395,423,568.68
减:库存股276,947,754.62275,000,000--
其他综合收益24,820,019.444,943,151.6834,021,350.3742,374,252.48
盈余公积84,000,00084,000,00084,000,00084,000,000
未分配利润6,450,517,323.766,561,066,091.636,645,320,084.796,712,673,580.19
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计6,880,382,859.037,012,382,661.197,360,714,853.047,436,071,401.35
少数股东权益170,844,462.57174,389,232.09176,105,312.78113,656,746.68
股东权益平衡项目0000
股东权益合计7,051,227,321.67,186,771,893.287,536,820,165.827,549,728,148.03
负债和股东权益合计8,234,404,013.888,442,942,831.418,759,354,189.438,995,951,150.74
公告日期2024-10-312024-08-302024-04-302024-04-30
审计意见(境内)标准无保留意见
TOP↑